Yajko DM |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? |
1992 |
Res. Microbiol. |
pmid:1455069
|
Yatera K et al. |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases. |
2017 |
Respir Investig |
pmid:29153420
|
Higashi F et al. |
Additional treatment with clarithromycin reduces fever duration in patients with influenza. |
2014 |
Respir Investig |
pmid:25169846
|
Suzuki K et al. |
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance. |
2018 |
Respir Investig |
pmid:29325687
|
Kadota J et al. |
Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. |
2003 |
Respir Med |
pmid:12854636
|
Miravitlles M et al. |
Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. |
2005 |
Respir Med |
pmid:15950136
|
Lode H et al. |
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia. |
2003 |
Respir Med |
pmid:14561021
|
Niederman MS et al. |
Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents. |
2006 |
Respir Med |
pmid:16531032
|
Hoeffken G et al. |
The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia. |
2001 |
Respir Med |
pmid:11453311
|
Hagberg L et al. |
Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis. |
2003 |
Respir Med |
pmid:12814146
|
Kohyama T et al. |
Clarithromycin inhibits fibroblast migration. |
2008 |
Respir Med |
pmid:18701271
|
Abe M et al. |
A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D4/E4 receptor antagonist. |
1998 |
Respir Med |
pmid:9893782
|
Kobashi Y et al. |
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. |
2007 |
Respir Med |
pmid:16750618
|
Simoens S et al. |
Preventing COPD exacerbations with macrolides: a review and budget impact analysis. |
2013 |
Respir Med |
pmid:23352223
|
Banerjee D et al. |
The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD. |
2005 |
Respir Med |
pmid:15715188
|
Carbon C et al. |
Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia. |
2006 |
Respir Med |
pmid:16376537
|
Persson CG and Uller L |
Resolution of cell-mediated airways diseases. |
2010 |
Respir. Res. |
pmid:20540713
|
Ballard HO et al. |
Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. |
2007 |
Respir. Res. |
pmid:17550598
|
Amado-RodrÃguez L et al. |
Anti-inflammatory effects of clarithromycin in ventilator-induced lung injury. |
2013 |
Respir. Res. |
pmid:23663489
|
Beigelman A et al. |
Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis. |
2010 |
Respir. Res. |
pmid:20591166
|
du Toit LC et al. |
Tuberculosis chemotherapy: current drug delivery approaches. |
2006 |
Respir. Res. |
pmid:16984627
|
Komiya K et al. |
Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts. |
2017 |
Respir. Res. |
pmid:28219384
|
Legssyer R et al. |
Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. |
2006 |
Respir. Res. |
pmid:17064416
|
Liapakis IE et al. |
Penetration of clarithromycin in experimental pleural empyema model fluid. |
2005 May-Jun |
Respiration |
pmid:15942299
|
Rovira E et al. |
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime. |
1999 |
Respiration |
pmid:10516537
|
Huchon G |
How to manage the low-risk patient with lower respiratory tract infection? |
1999 |
Respiration |
pmid:10577170
|
Kobashi Y and Matsushima T |
The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study. |
2007 |
Respiration |
pmid:16954651
|
Jouneau S et al. |
Clarithromycin stops lung function decline in airway-centered interstitial fibrosis. |
2013 |
Respiration |
pmid:23095475
|
Fujiuchi S et al. |
Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease. |
2003 Jan-Feb |
Respiration |
pmid:12584395
|
Soepandi P et al. |
The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections. |
1998 |
Respirology |
pmid:9692520
|
Ruiz-González A et al. |
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. |
2007 |
Respirology |
pmid:17207036
|
Ding FM et al. |
Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection. |
2012 |
Respirology |
pmid:22404374
|
Strouvalis I et al. |
Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence. |
2018 |
Respirology |
pmid:29741298
|
Kobashi Y et al. |
Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease. |
2006 |
Respirology |
pmid:17052313
|
Sawabuchi T et al. |
Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza. |
2009 |
Respirology |
pmid:19909463
|
Okimoto N et al. |
Clinical features of Q fever pneumonia. |
2004 |
Respirology |
pmid:15182283
|
Kikuchi E et al. |
Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid. |
2008 |
Respirology |
pmid:18339019
|
Isozumi R et al. |
Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae. |
2009 |
Respirology |
pmid:19732389
|
Matieli LC et al. |
Mycobacterium abscessus endophthalmitis: treatment dilemma and review of the literature. |
2006 |
Retina (Philadelphia, Pa.) |
pmid:16963860
|
Unal M et al. |
Ocular toxicity of intravitreal clarithromycin. |
1999 |
Retina (Philadelphia, Pa.) |
pmid:10546942
|
MorfÃn Maciel BM and Castillo Ramos HA |
[Reactive polyarthritis and painful dermatographism caused by Helicobacter pylori]. |
2002 May-Jun |
Rev Alerg Mex |
pmid:12190006
|
Cofré Guerra J |
[Pertussis chemoprophylaxis: a sterile effort?]. |
2006 |
Rev Chilena Infectol |
pmid:16462967
|
Olmos MartÃnez JM et al. |
[Definitive treatment of Helicobacter pylori infection in MALT low degree gastric lymphoma]. |
2003 |
Rev Clin Esp |
pmid:14622518
|
Alba D et al. |
[Clarithromycin in the treatment of cerebral toxoplasmosis associated with HIV infection]. |
1993 |
Rev Clin Esp |
pmid:8516514
|
DÃaz F et al. |
[Cat-scratch disease. A report of 4 cases and a review of the literature]. |
1997 |
Rev Clin Esp |
pmid:9102668
|
Baena DÃez JM et al. |
[Are 5 days of omeprazole plus 2 antibiotics enough for eradication of H. pylori? Comments on sample size]. |
1999 |
Rev Clin Esp |
pmid:10432821
|
Gisbert JP et al. |
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?]. |
1998 |
Rev Clin Esp |
pmid:9844453
|
Gisbert JP et al. |
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori]. |
1998 |
Rev Clin Esp |
pmid:9844458
|
Asencio Marchante R and Lissen Otero E |
[Secondary prevention of opportunistic infections in HIV-infected patients]. |
2001 |
Rev Clin Esp |
pmid:11345612
|
Murcia J et al. |
[Acute myocardial failure in a young man: Q-fever myocarditis]. |
2002 |
Rev Esp Cardiol |
pmid:12199986
|
Vallejo Camazón N et al. |
[Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection]. |
2002 |
Rev Esp Cardiol |
pmid:12199987
|
Garza González E et al. |
[Helicobacter pylori erradication and its relation to antibiotic resistance and CYP2C19 status]. |
2007 |
Rev Esp Enferm Dig |
pmid:17417917
|
de Artaza Varasa T et al. |
[Effect of Helicobacter pylori eradication on patients with functional dyspepsia]. |
2008 |
Rev Esp Enferm Dig |
pmid:19025303
|
Gisbert JP et al. |
[What is the current role of clarithromycin in the eradication of Helicobacter pylori?]. |
1997 |
Rev Esp Enferm Dig |
pmid:9221019
|
Rodrigo Sáez L et al. |
[The efficacy of using a short course of 6-day duration (OCA-6) in the treatment to eradicate Helicobacter pylori infection. Omeprazole, clarithromycin, amoxicillin]. |
1997 |
Rev Esp Enferm Dig |
pmid:9115827
|
Sainz R et al. |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. |
1999 |
Rev Esp Enferm Dig |
pmid:10601771
|
Rojas Feria M et al. |
Resistance of Helicobacter pylori to antimicrobial treatment in a Seville hospital catchment area. |
2000 |
Rev Esp Enferm Dig |
pmid:11468787
|
RodrÃguez Téllez M et al. |
Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection. |
1999 |
Rev Esp Enferm Dig |
pmid:10491487
|
Gisbert JP |
[Lansoprazole: a review of its role in Helicobacter pylori eradication therapy]. |
1999 |
Rev Esp Enferm Dig |
pmid:10231305
|
González Carro P et al. |
[Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori]. |
1998 |
Rev Esp Enferm Dig |
pmid:9780793
|
Boixeda D et al. |
Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success. |
2003 |
Rev Esp Enferm Dig |
pmid:12760710
|
Gisbert JP et al. |
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment. |
2003 |
Rev Esp Enferm Dig |
pmid:12760719
|
Torres-Debat ME et al. |
Antimicrobial susceptibility of Helicobacter pylori and mechanisms of clarithromycin resistance in strains isolated from patients in Uruguay. |
2009 |
Rev Esp Enferm Dig |
pmid:20001152
|
Boixeda de Miquel D |
[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer]. |
1997 |
Rev Esp Enferm Dig |
pmid:9494374
|
Pérez Mota A et al. |
Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules. |
1997 |
Rev Esp Enferm Dig |
pmid:9494375
|
Castro-Fernández M et al. |
Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori. |
2009 |
Rev Esp Enferm Dig |
pmid:19630462
|
Fernández Martos R et al. |
Acute psychotic episode secondary to Helicobacter pylori eradication treatment. |
2017 |
Rev Esp Enferm Dig |
pmid:28071063
|
Carabias ML et al. |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study]. |
2001 |
Rev Esp Quimioter |
pmid:11704772
|
Gordillo RM et al. |
[Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)]. |
2003 |
Rev Esp Quimioter |
pmid:12750758
|
Cantón E et al. |
[In vitro susceptibility to antibiotics and the most common Streptococcus pneumoniae serotypes: a multicenter study]. |
2005 |
Rev Esp Quimioter |
pmid:15915232
|
Agudo S et al. |
Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism. |
2011 |
Rev Esp Quimioter |
pmid:21412667
|
DÃaz-Reganon J et al. |
[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors]. |
2006 |
Rev Esp Quimioter |
pmid:16688289
|
Agudo S et al. |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children]. |
2009 |
Rev Esp Quimioter |
pmid:19544100
|
Orellana MA and Gómez-Lus ML |
[Which is the best empirical treatment in patients with urethritis?]. |
2011 |
Rev Esp Quimioter |
pmid:21947096
|
Vega AE et al. |
[Detection of resistance to clarithromycin in clinical isolates of Helicobacter pylori from children and adults]. |
2003 |
Rev Esp Quimioter |
pmid:12750757
|
Ruiz-Aragón J et al. |
[Susceptibility to antimicrobial agents of rapidly growing mycobacteria]. |
2007 |
Rev Esp Quimioter |
pmid:18563216
|
Guirao-Arrabal E et al. |
Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci. |
2016 |
Rev Esp Quimioter |
pmid:26888341
|
Miglietta F et al. |
A rare case of Saprochaete capitata fungemia in a critical ill patient without hematologic and oncological disorders. |
2016 |
Rev Esp Quimioter |
pmid:26785226
|
Gálvez-Múgica MA et al. |
[Meta-analysis of clarithromycin compared to other antibiotics for the treatment of lower respiratory tract infections]. |
2003 |
Rev Esp Quimioter |
pmid:14961134
|
Alarcón T et al. |
[In vitro activity of clarithromycin and metronidazole against Helicobacter pylori in different incubation atmospheres]. |
2002 |
Rev Esp Quimioter |
pmid:12587039
|
Rubio-Terrés C et al. |
[Pharmacoeconomic analysis of community-acquired pneumonia treatment with telithromycin or clarithromycin]. |
2003 |
Rev Esp Quimioter |
pmid:14702121
|
Abad-Santos F et al. |
[Meta-analysis of clarithromycin compared with other antimicrobial drugs in the treatment of upper respiratory tract infections]. |
2003 |
Rev Esp Quimioter |
pmid:14702124
|
Alarcón T et al. |
[In vitro activity of furazolidone and nitrofurantoin in Helicobacter pylori clinical isolates and study of mutation rate]. |
2005 |
Rev Esp Quimioter |
pmid:16446791
|
Abasolo Osinaga E et al. |
[Dispensation and cost of antimicrobials in Spain (1998-2000)]. |
2005 |
Rev Esp Quimioter |
pmid:16446789
|
Orden MartÃnez B et al. |
[Haemophilus spp. antimicrobial susceptibility in Health Area 6 in Madrid, Spain (2000-2004)]. |
2005 |
Rev Esp Quimioter |
pmid:16130040
|
Vakil N |
Helicobacter pylori treatment: is sequential or quadruple therapy the answer? |
2008 |
Rev Gastroenterol Disord |
pmid:18641590
|
Guarner J and Mohar A |
[The association between Helicobacter pylori and gastric neoplasia. Epidemiologic evidence]. |
2000 Oct-Dec |
Rev Gastroenterol Mex |
pmid:11464618
|
Ladrón de Guevara L et al. |
[Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment]. |
2004 Oct-Dec |
Rev Gastroenterol Mex |
pmid:15765971
|
Dehesa M et al. |
[Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer]. |
1998 Apr-Jun |
Rev Gastroenterol Mex |
pmid:10068730
|
RamÃrez Ramos A |
[Treatment of Helicobacter pylori infection: current status]. |
1995 |
Rev Gastroenterol Peru |
pmid:8520021
|
RodrÃguez W et al. |
[Omeprazole, amoxicillin and clarithromycin in the treatment of helicobacterpylori, in 7 and 10-day regimens]. |
2003 Jul-Sep |
Rev Gastroenterol Peru |
pmid:14532918
|
Velasco BenÃtez CA and Amorocho Pérez RD |
[Treatment of gastritis-associated Helicobacter pylori infection in children]. |
2002 Apr-Jun |
Rev Gastroenterol Peru |
pmid:12098744
|
Silva FM et al. |
Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer. |
2001 Jan-Feb |
Rev Hosp Clin Fac Med Sao Paulo |
pmid:11378678
|
Pinto LA et al. |
Effect of clarithromycin on the cell profile of bronchoalveolar lavage fluid in mice with neutrophil-predominant lung disease. |
2004 |
Rev Hosp Clin Fac Med Sao Paulo |
pmid:15286828
|
Souza R et al. |
Diffuse panbronchiolitis: an underdiagnosed disease? Study of 4 cases in Brazil. |
2002 Jul-Aug |
Rev Hosp Clin Fac Med Sao Paulo |
pmid:12244337
|
|
[Zeclar, a new antibiotic (clarithromycin 250 mg from Abbott laboratories]. |
1994 |
Rev Infirm |
pmid:7652424
|
Job V et al. |
[Medical-surgical treatment of pulmonary infection with Mycobacterium malmoense]. |
2004 |
Rev Mal Respir |
pmid:15622347
|
Schubel K et al. |
[Pleuropneumonia due to Mycobacterium chelonae]. |
2011 |
Rev Mal Respir |
pmid:21482339
|
Ramon PM et al. |
[Uveitis, arthralgia and pseudo-jaundice in a HIV seronegative patient due to rifabutin]. |
1998 |
Rev Mal Respir |
pmid:9608993
|
Gomez-Abreo D et al. |
[Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]. |
2012 |
Rev Mal Respir |
pmid:22440310
|